The company is engaged in production of leading generic APIs, Nutraceutical ingredients and custom synthesis of APIs and intermediates for global companies.
It has a product portfolio of 122 products across various therapeutic areas.
Current Price
₹ 3,278
Stock P/E
29.1 , after 3 years it is back to Median PE of 29
Book Value
₹ 457
Promoter holding
51.9 %
Debt
₹ 3.29 Cr.
Pledged percentage
0.00 %
Debt to equity
0.00
Price to book value
7.13
PEG Ratio
1.28
Stock is below 200 / 100 / 63/21/10 EMA
BELOW 50% Retracement in Fibnocci
Can be accumulated for long-term / SIP , considering its fundamentals
It has a product portfolio of 122 products across various therapeutic areas.
Current Price
₹ 3,278
Stock P/E
29.1 , after 3 years it is back to Median PE of 29
Book Value
₹ 457
Promoter holding
51.9 %
Debt
₹ 3.29 Cr.
Pledged percentage
0.00 %
Debt to equity
0.00
Price to book value
7.13
PEG Ratio
1.28
Stock is below 200 / 100 / 63/21/10 EMA
BELOW 50% Retracement in Fibnocci
Can be accumulated for long-term / SIP , considering its fundamentals
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.